The use of a balloon-expandable valve in tricuspid valve-in-valve (ViV) procedures has shown favorable outcomes, especially for treating bioprosthetic valve failure, with improvements seen after one year of follow-up. However, this highlights the complexity of patient selection and the need to carefully consider anatomical constraints, particularly in high-risk populations Mussayev et al. Another study compared percutaneous annuloplasty and transcatheter edge-to-edge repair (T-TEER) for severe tricuspid regurgitation (TR), underscoring the challenges related to anatomical suitability and learning curves associated with each technique Mattig et al.

Addressing complications such as paravalvular leak (PVL) after initial TAVR procedures remains a significant technical challenge. A study on TAVR-in-TAVR procedures using balloon-expandable valves showed high procedural success and favorable long-term outcomes for addressing PVL, yet the complexity of these interventions underscores the need for continued device innovation Nagasaka et al. Another study on left atrial appendage occlusion (LAAO) highlighted differences in procedural complexity and outcomes when comparing single-occlusive plug-type devices to dual-occlusive disc-type devices, revealing important technical considerations that affect procedural success and complication rates Primessnig et al.

Post-procedural complications such as pacemaker dependency remain a concern, particularly after TAVR with certain valve models. A comparison between the Portico and Edwards Sapien 3 valves in TAVR revealed that the Portico valve was associated with higher rates of permanent pacemaker implantation, indicating the importance of valve design in reducing complications Primessnig et al. In a study of intra-atrial shunt occlusion in older patients following embolic stroke of undetermined source, the procedure was shown to be safe and effective, although long-term outcomes in this high-risk population require further evaluation Schrader et al.

Technological advancements in valve design are helping to address many of the challenges described above. Balloon-expandable valves, such as those used in the tricuspid ViV and TAVR-in-TAVR procedures, have demonstrated improved procedural outcomes, reducing the need for post-procedural interventions and improving long-term valve function Mussayev et al. and Nagasaka et al. Similarly, the Edwards Sapien 3 valve has demonstrated a favorable complication profile compared to older valve models like the Portico, further highlighting the importance of valve design in optimizing outcomes Primessnig et al.

Hybrid approaches that combine percutaneous annuloplasty with T-TEER have shown potential in improving outcomes for patients with severe TR, providing a more tailored approach to complex cases Mattig et al. These hybrid strategies may expand in the future as technologies evolve and procedural techniques are refined.

The future of TVIs lies in expanding indications beyond high-risk populations. As technology improves, TVIs are being explored for younger and lower-risk patients. For example, the successful occlusion of intra-atrial shunts in older patients with embolic stroke suggests that minimally invasive techniques can be applied safely and effectively in broader populations, including those with complex pathologies Schrader et al.

As seen in the comparison of the Portico and Edwards Sapien 3 valves, personalization of valve choice based on patient-specific factors will be crucial in optimizing outcomes and reducing complications Primessnig et al. This emphasis on personalized intervention will likely play a significant role in the future of TVIs, particularly as we expand the use of these technologies to more diverse patient populations.